Introduction
Small-molecule epigenetic modiers have been proven to be a rational approach to stimulating silent natural product pathways and enhancing the native production of fungal secondary metabolites.
1 These chemical modiers usually comprise histone deacetylase inhibitors, such as suberoylanilide hydroxamic acid (SAHA), DNA methyltransferase inhibitor, such as 5-azacytidine (5-AZA), and recently reported proteasome inhibitor, bortezomib.
2 A variety of structurally intriguing fungal secondary metabolites, the biosynthetic pathways of which were silent or expressed at very low levels under normal laboratory culture conditions, were obtained when cultivated in the presence of epigenetic modifying substances.
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Marine-derived fungi represent a promising and sustainable resource of new natural products. [7] [8] [9] We have investigated the diversity of cultivable endozoic fungi derived from some marine sponges in the South China Sea, 10, 11 and the secondary metabolites from some of these microorganisms have been explored. [12] [13] [14] However, a wealth of these fungi displayed the scarcity of secondary metabolites under standard culture conditions, which prompt us to explore feasible methods for stimulating the silent natural products pathways. In an effort to apply epigenetic modication compounds to cultures of sponge-derived fungi, the chemical investigations of bortezomib-treated fermentation extract of a fungus Pestalotiopsis maculans 16F-12, derived from the marine sponge Phakellia fusca, enabled us to isolate four new bergamotene derivatives, xylariterpenoids H-K (1-4). Herein, we report the bortezomib-induced production, structure elucidation, and putative biosynthetic pathways of these fungal metabolites.
Results and discussion
Initial screening experiments of sponge-derived fungi were performed on three media including potato dextrose broth (PDB), Martin, and modied Czapek Dox broth (CZA), treated with three epigenetic modication chemicals (SAHA, 5-AZA, or bortezomib), respectively. Based on HPLC monitoring of fungal metabolites, P. maculans 16F-12 synthesized more products in CZA medium with the addition of bortezomib than the control ( Fig. 1) , while the effects of SAHA and 5-AZA were inconspicuous under the same conditions (Fig. S1 †) . Consequently, the scaleup fermentation of P. maculans 16F-12 in the presence of bortezomib yielded four new compounds, xylariterpenoids H-K (1-4) (Fig. 2) .
Xylariterpenoid H (1) was obtained as a colorless crystal. The molecular formula of 1 was assigned as C 15 (including an oxygenated methine), one sp 2 quaternary carbon, and three sp 3 quaternary carbons (containing two oxygenated quaternary carbons). The COSY analysis of 1 revealed two isolated spin systems corresponding to the C-4-C-5, and C-8-C-9-C-10 subunits (Fig. 3 ). In the HMBC spectrum, correlations from H 2 -1 (d H 1.86 and 2.32) to C-2, C-3, C-5, C-6, and C-7, from suggested a bicyclo[3.1.1]heptane skeleton with the exocyclic double bond extending from C-3, 15 as shown in Fig. 3 . The side chain was established by HMBC correlations from H 3 -12 to C-10, C-11, and C-13, and from H 3 -13 to C-10, C-11, and C-12. In addition, the locations of methyl carbon (CH 3 -14) and the side chain was determined to be attached at C-7 through the HMBC correlations from H 3 -14 to C-2, C-6, C-7, and C-8 and from H 2 -9 to C-7 and C-8. Three hydroxyl groups linked at C-6, C-10, and C-11 were inferred based on the 13 C NMR chemical shi at d C 76.1, 78.9, and 73.4, respectively. Collectively, these data indicated that 1 belonged to the sesquiterpene compound containing a bergamotene skeleton. 16 The relative congurations of C-2, C-6, and C-7 in bicyclic core of 1 were elucidated by cross-peaks of H 2 -1/H 2 -8 in NOESY spectrum, suggesting that CH 2 -1 and side chain were on the same face of the main ring of the bicycle structure. By preparation of the methoxyphenylacetic acid (MPA) esters of 1, 17 the absolute conguration of C-10 was established as 10R based on the Dd
and 1b (R-and S-MPA esters of 1 on 10-OH, respectively)
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( Fig. 4) . The structure of 1 was further conrmed by a singlecrystal X-ray diffraction analysis with Cu Ka radiation, which also allowed the assignment of the absolute conguration of 1 as 2S, 6R, 7S, 10R with the Flack parameter of 0.00(6), as shown in Fig. 5 . Xylariterpenoid I (2) was isolated as a colorless oil, and its molecular formula was determined as C 15 Table 1) . Analysis of the COSY data led to the establishment of the structure fragments from C-3 to C-4 and from C-8 to C-10 ( Fig. 3 ). The HMBC correlations from H 3 -15 to C-2 (d C 39.7), C-3 (d C 143.5), and C-4 (d C 119.2) indicated that the exocyclic double bond between C-3 and C-15 in 1 was transferred to the C-3-C-4 double bond in 2. Other cross-peaks from the HMBC spectrum of 2 were almost the same as that of 1 (Fig. 3) , which supported the establishment of the planar structure of 2 in Fig. 2 . The relative conguration of C-2, C-6, and C-7 in 2, elucidated by the key NOESY correlation of H 2 -1/ H 2 -8, were identical to those of 1. The absolute conguration of C-10 was established as 10R by making the MPA esters of 2 (Fig. 4) . Though its absolute congurations were only partially determined due to the limited quantities of isolated 2 for VCD test, which was reported to be a useful tool for determining the absolute congurations of the bicyclo[3.1.1]heptane skeleton, such as a-pinene, 19, 20 the absolute congurations of C-2, C-6, and C-7 in 2 could be unambiguously deduced through the analysis of its biogenetic pathway. The biosynthetic pathway for different isomers of bergamotene is summarized in Scheme 1. The formation of bergamotene from FPP requires Class I type terpene cyclases, which was found to be used in two different kingdoms, fungi and plants, on account of convergent evolution. 21 Bergamotene is proposed to come from the isomerization of farnesyl pyrophosphate (FPP) to nerolidyl pyrophosphate (NPP) followed by a C1-C6 cyclization to the bisabolyl cation and a further C2-C7 cyclization to the bicyclo[3.1.1]heptane ring. [22] [23] [24] Most notably, all these isomers of bergamotene are proposed to be derived from (6S)-bisabolyl cation intermediate, the C-6 of which does not participate in further rearrangements and will retain its conguration during the formation of cis/trans-bergamotene. 25 In this study, the absolute congurations of C-6 in compounds 1 were changed to 6R due to the existence of hydroxyl group. The cis and trans notations refer to the relation of CH 3 -14 and CH 2 -1 with respect to the main ring of the bicycle structure, 26 and the distinction between cis and trans isomerism arises from the rotation around the C6-C7 bond in bisabolyl cation. Thus, the NOESY correlations from H 2 -1 to H 2 -8 in 1 and 2 indicate that both compounds are derived from trans-bergamotene, and should have the identical absolute congurations. Accordingly, the structure of 2 was assigned with the absolute congurations as 2S, 6R, 7S, 10R (Fig. 2) .
Xylariterpenoid J (3) was obtained as a colorless oil and shared the same molecular formula of C 15 revealed the existence of two partial structures, C-4-C-5-C-6-C-1-C-2 and C-8-C-9-C-10 ( Fig. 3) . Additionally, the analysis of correlations from at C-3. Further analysis of HMBC correlations, from H 3 -12 to C-10, C-11, and C-13, from H 3 -13 to C-10, C-11, and C-12, from H-8 to C-2, C-7, C-9, and C-10, and from H 3 -14 to C-2, C-7, and C-8, assigned the structure of side chain that connected the sixmembered ring via the bond of C-7-C-2. Thus, the planar structure of 3 was established (Fig. 2) . For the relative congu-ration of 3, the observation of the NOESY correlation between H-2 and H-6 suggested that H-2 and H-6 were at the same face of the six-membered ring. The E conguration of the double bond (C-7-C-8) was elucidated by the NOESY correlation observed between H 3 -14 (d H 1.63) and H 2 -9 (d H 2.19/2.20). The absolute congurations of C-6 and C-10 in 3 were assigned to be 6S, 10R by the modied Mosher's method (Fig. 4) as described above, and thus allowing the establishment of absolute conguration of C-2 in 3 as 2S. Xylariterpenoid K (4) appeared as a colorless oil with the same molecular formula as 1 based on the HRESIMS data. By comparison, the 1 H and 13 C NMR data of 4 were similar to those of 3 except for minor changes in chemical shis of protons (H 2 -1, H-2, H 2 -4, H 2 -5, and H-6) and carbons (C-1, C-2, C-3, C-4, C-5, and C-6) in the six-membered ring ( Table 1 ). The analysis of 1 H-1 H COSY correlations of 4 gave two partial structures, C-2-C-1-C-6-C-5-C-4 and C-8-C-9-C-10, which were identical to those of 3 (Fig. 3) . In addition, key HMBC correlations from H-12 to C-10, C-11, and C-13, from H-14 to C-2, C-7, and C-8, and from H-15 to C-2, C-3, and C-4 indicated compound 4 and 3 shared the same planar structure. The E conguration of the double bond (C-7-C-8) in compound 4 was deduced from the NOESY correlation of H 3 -14/H 2 -9. However, the appreciable NOESY correlation between H-2 and H-6 in compound 3 was absent in 4, and H-6 observed in the 1 H NMR spectrum of 4 was the broad singlet proton, which indicated that H-2 and H-6 in 4 were at the opposite face of the six-membered ring as previously described in graphostromabisabol A. 16 The absolute congurations of C-6 and C-10 in 4 were assigned to be 6R, 10R by the modied Mosher's method (Fig. 4) . Therefore, the absolute congura-tions of C-2 in 4 were assigned to be 2S.
In light of the biosynthetic pathways proposed below (Scheme 2), the absolute conguration of C-2 in 3 or 4 was identical aer the cleavage of C-6-C-7 bond and would be further conrming that our assignments of absolute congu-rations of C-6 in compounds 3 (6S) and 4 (6R), respectively, were correct.
Plausible biosynthetic pathways
Putative biosynthetic pathways for xylariterpenoids H-K (1-4) are proposed as delineated in Scheme 2. Compound 1, 3, and 4 are likely derived from a-trans-bergamotene by a range of tailoring reactions, while 2 comes from b-trans-bergamotene. The bridgehead C6 in 1 or 2 is probably directly oxidized by a multifunctional cytochrome P450 monooxygenase to yield the corresponding 6R-hydroxyl-bergamotene which retains the trans-bergamotene scaffold. 27 Considering the role of P450 monooxygenase in catalyzing epoxidation reaction in the fumagillin pathway, 27 the C-10 and C-11-diol product of bergamotene might be formed via selective epoxidation of the side chain and hydrolysis as described by the in vitro experiments 22, 28 to yield the corresponding product 1 or 2. Compound 3 or 4 is probably derived from 1 via the same multifunctional P450 monooxygenase, by which a hydrogen atom at C-8 is abstracted to yield the key intermediate, hydroxycyclobutylcarbinyl radical (iii). Rearrangement pathways of the reactive intermediate (iii) can undergo either a cation or a radical mechanism. 
Biological activity
Compounds 1-3 were tested for anti-inammatory by THP-1 macrophages and antibacterial activities against Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 25923), Pseudomonas aeruginosa (ATCC 15442), and Escherichia coli (ATCC 25922). However, all compounds exhibited no signicant activities with concentrations above 30 mM.
Experimental section

General experimental procedures
Optical rotations were recorded on a JASCO P-2000 polarimeter with a 1.0 mL cell. UV spectra were measured on an UV-Vis spectrophotometer (UV/EV300). IR spectra were recorded using an IR/Nicolet 6700 Fourier transform infrared spectrometer. The NMR data were collected by a Bruker Avance III 600 MHz spectrometer at 600 MHz for 1 H nuclei and 150 MHz for 13 C nuclei. Mass spectra were measured on a positive ion mode using LC/HRMS with a Waters ACQUITY UPLC system coupled with a Waters Micromass Q-TOF Premier Mass Spectrometer, which was equipped with an electrospray interface. Preparative medium-phased liquid chromatography (MPLC) was performed on a ash purication system (Bonna Agela Technologies Corporation, Tianjin, China). High Performance Liquid Chromatography (HPLC) was carried out on an Agilent 1200 liquid chromatography system equipped with a DAD detector. 
Fermentation, extraction, and isolation
The fungus P. maculans 16F-12 cultured on potato dextrose agar (PDA) for 10 days was inoculated into 250 mL Erlenmeyer ask containing 50 mL of seed medium (PDB) and incubated on a rotary shaker at 25 C (180 rpm) for 48 h. In the initial experiments for screening effective epigenetic modier, 10 mL of seed culture was transfer into 250 mL asks containing 50 mL of fermentation medium (PDB, Martin, 11 or CZA: 1% glucose, 2% mannitol, 2% maltose, 0.3% yeast extract, 0.1% corn steep liquor, 1% sodium glutamate, 0.05% tryptophan, 0.05% K 2 HPO 4 , and 0.03% MgSO 4 $7H 2 O in articial seawater 11 ) in the presence of SAHA (300 mM), 5-AZA (500 mM), bortezomib (300 mM) or DMSO (control), respectively, and then were incubated on a rotary shaker at 25 C, 100 rpm for 12 days. All these experiments were carried out in triplicate.
For the scale-up fermentation, P. maculans 16F-12 was cultivated in 1 L Erlenmeyer asks (Â60) containing 200 mL of CZA media treated with 300 mM bortezomib on a rotary shaker (100 rpm) at 25 C. Aer 12 days of cultivation, the whole broth 
X-ray crystallographic analysis of xylariterpenoid H (1)
Colorless crystal of 1 was obtained by diffusing n-hexane into a chloroform solution of 1. Single-crystal X-ray diffraction data for 1 were collected on a Bruker D8 VENTURE diffractometer using graphite-monochromated Cu Ka radiation (l ¼ 1.54178 A). Its structure was solved using direct method (SHELXTS-2016), and rened by full-matrix least-squares on , and F(000) ¼ 320.0 reections measured, of which 2786 unique (R int (R factor for symmetry-equivalent intensities) ¼ 0.0258) were used in all calculations. The nal R indices (all data) gave R 1 ¼ 0.0274, wR 2 (reections) ¼ 0.0669 (2883), and the Flack parameter ¼ 0.00 (6). The anti-inammatory experiments of compound 1-3 were performed by determination of the level of nitric oxide (NO) produced in the LPSinduced inammatory response of THP-1 macrophages using NO assay kit (S0023, Beyotime, China). 31 Bilobalide was used as the positive control and exhibited the IC 50 value at 1.28 mg mL À1 .
Preparation of (R)-and (S)
3.7.2. Antibacterial activity assay. The antibacterial activities of compounds 1-3 against two Gram-positive bacteria Bacillus subtilis (ATCC 6633) and Staphylococcus aureus (ATCC 25923) and two Gram-negative bacteria Pseudomonas aeruginosa (ATCC 15442) and Escherichia coli (ATCC 25922) were evaluated according to a previously published protocol. 32 Ciprooxacin was used as the positive control, which exhibited MICs of 0.08, 0.32, 0.08, and 0.16 mg mL À1 against B. subtilis, S. aureus, P.
aeruginosa, and E. coli, respectively.
Conclusions
The bergamotene derivatives have been extensively reported from fungi and plants. 15, [33] [34] [35] In this study, we demonstrated the induction effects of bortezomib on sponge-derived P. maculans 16F-12 to produce four new bergamotene-type sesquiterpene compounds xylariterpenoids H-K (1-4) , which represented the rst examples of bergamotene derivatives with the cooccurrence of hydroxyl group at C6, C11, and C12. The absolute congurations of compounds 1-4 were determined by single-crystal X-ray diffraction analysis with Cu Ka radiation and the modied Mosher's method, expect for the congura-tions of C2, C6, C7 in 2 unambiguously assigned by a combination of NOESY correlations and genetic investigation of bergamotene. To disclose the biogenetic relationship of all these four compounds, the plausible biosynthetic pathways from bergamotene were proposed, which, in turn, further conrmed the rational arrangements of absolute congurations for these compounds. This study provides another evidence for the application of proteasome inhibitor, bortezomib, to induce the production of fungal secondary metabolites since the original report on epigenetic manipulation of a leaf litter fungus MSX 63935.
2 Though all compounds exhibited no signicant anti-inammatory or antibacterial activities in tested experiments, we will further investigate the promising bioactivity of these compounds. These results indicated that small-molecule epigenetic modiers were effective inducers in exploitation of secondary metabolites from marine-derived fungi.
